- •Preface and Acknowledgments
- •Contents
- •Contributors
- •1: Embryology for Urologists
- •Introduction
- •Renal Development
- •Pronephros
- •Mesonephros
- •Metanephros
- •Development of the Collecting System
- •Critical Steps in Further Development
- •Anomalies of the Kidney
- •Renal Agenesis
- •Renal Aplasia
- •Renal Hypoplasia
- •Renal Ectopia
- •Renal Fusion
- •Ureteral Development
- •Anomalies of Origin
- •Anomalies of Number
- •Incomplete Ureteral Duplication
- •Complete Ureteral Duplication
- •Ureteral Ectopia
- •Embryology of Ectopia
- •Clinical Correlation
- •Location of Ectopic Ureteral Orifices – Male (in Descending Order According to Incidence)
- •Symptoms
- •Ureteroceles
- •Congenital Ureteral Obstruction
- •Pipestem Ureter
- •Megaureter-Megacystis Syndrome
- •Prune Belly Syndrome
- •Vascular Ureteral Obstructions
- •Division of the Urogenital Sinus
- •Bladder Development
- •Urachal Anomalies
- •Cloacal Duct Anomalies
- •Other Bladder Anomalies
- •Bladder Diverticula
- •Bladder Extrophy
- •Gonadal Development
- •Testicular Differentiation
- •Ovarian Differentiation
- •Gonadal Anomalies
- •Genital Duct System
- •Disorders of Testicular Function
- •Female Ductal Development
- •Prostatic Urethral Valves
- •Gonadal Duct Anomalies
- •External Genital Development
- •Male External Genital Development
- •Female External Genital Development
- •Anomalies of the External Genitalia
- •References
- •2: Gross and Laparoscopic Anatomy of the Upper Urinary Tract and Retroperitoneum
- •Overview
- •The Kidneys
- •The Renal Vasculature
- •The Renal Collecting System
- •The Ureters
- •Retroperitoneal Lymphatics
- •Retroperitoneal Nerves
- •The Adrenal Glands
- •References
- •3: Gross and Laparoscopic Anatomy of the Lower Urinary Tract and Pelvis
- •Introduction
- •Female Pelvis
- •Male Pelvis
- •Pelvic Floor
- •Urinary Bladder
- •Urethra
- •Male Urethra
- •Female Urethra
- •Sphincter Mechanisms
- •The Bladder Neck Component
- •The Urethral Wall Component
- •The External Urethral Sphincter
- •Summary
- •References
- •4: Anatomy of the Male Reproductive System
- •Testis and Scrotum
- •Spermatogenesis
- •Hormonal Regulation of Spermatogenesis
- •Genetic Regulation of Spermatogenesis
- •Epididymis and Ductus Deferens
- •Accessory Sex Glands
- •Prostate
- •Seminal Vesicles
- •Bulbourethral Glands
- •Penis
- •Erection and Ejaculation
- •References
- •5: Imaging of the Upper Tracts
- •Anatomy of the Upper Tracts and Introduction to Imaging Modalities
- •Introduction
- •Renal Upper Tract Basic Anatomy
- •Modalities Used for Imaging the Upper Tracts
- •Ultrasound
- •Radiation Issues
- •Contrast Issues
- •Renal and Upper Tract Tumors
- •Benign Renal Tumors
- •Transitional Cell Carcinoma
- •Renal Mass Biopsy
- •Renal Stone Disease
- •Ultrasound
- •Plain Radiographs and IVU
- •Renal Cystic Disease
- •Benign Renal Cysts
- •Hereditary Renal Cystic Disease
- •Complex Renal Cysts
- •Renal Trauma
- •References
- •Introduction
- •Pathophysiology
- •Susceptibility and Resistance
- •Epidemiological Breakpoints
- •Clinical Breakpoints
- •Pharmacodynamic Parameters
- •Pharmacokinetic Parameters
- •Fosfomycin
- •Nitrofurantoin
- •Pivmecillinam
- •b-Lactam-Antibiotics
- •Penicillins
- •Cephalosporins
- •Carbapenems
- •Aminoglycosides
- •Fluoroquinolones
- •Trimethoprim, Cotrimoxazole
- •Glycopeptides
- •Linezolid
- •Conclusion
- •References
- •7: An Overview of Renal Physiology
- •Introduction
- •Body Fluid Compartments
- •Regulation of Potassium Balance
- •Regulation of Acid–Base Balance
- •Diuretics
- •Suggested Reading
- •8: Ureteral Physiology and Pharmacology
- •Ureteral Anatomy
- •Modulation of Peristalsis
- •Ureteral Pharmacology
- •Conclusion
- •References
- •Introduction
- •Afferent Signaling Pathways
- •Efferent Signaling
- •Parasympathetic Nerves
- •Sympathetic Nerves
- •Vesico-Spinal-Vesical Micturition Reflex
- •Peripheral Targets
- •Afferent Signaling Mechanisms
- •Urothelium
- •Myocytes
- •Cholinergic Receptors
- •Muscarinic Receptors
- •Nicotinic Receptors
- •Adrenergic Receptors (ARs)
- •a-Adrenoceptors
- •b-Adrenoceptors
- •Transient Receptor Potential (TRP) Receptors
- •Phosphodiesterases (PDEs)
- •CNS Targets
- •Opioid Receptors
- •Serotonin (5-HT) Mechanisms
- •g-Amino Butyric Acid (GABA) Mechanisms
- •Gabapentin
- •Neurokinin and Neurokinin Receptors
- •Summary
- •References
- •10: Pharmacology of Sexual Function
- •Introduction
- •Sexual Desire/Arousal
- •Endocrinology
- •Steroids in the Male
- •Steroids in the Female
- •Neurohormones
- •Neurotransmitters
- •Dopamine
- •Serotonin
- •Pharmacological Strategies
- •CNS Drugs
- •Enzyme-inducing Antiepileptic Drugs
- •Erectile Function
- •Ejaculatory Function
- •Premature Ejaculation
- •Abnormal Ejaculation
- •Conclusions
- •References
- •Epidemiology
- •Calcium-Based Urolithiasis
- •Uric Acid Urolithiasis
- •Infectious Urolithiasis
- •Cystine-Based Urolithiasis
- •Aims
- •Who Deserves Metabolic Evaluation?
- •Metabolic Workup for Stone Producers
- •Medical History and Physical Examination
- •Stone Analysis
- •Serum Chemistry
- •Urine Evaluation
- •Urine Cultures
- •Urinalysis
- •Twenty-Four Hour Urine Collections
- •Radiologic Imaging
- •Medical Management
- •Conservative Management
- •Increased Fluid Intake
- •Citrus Juices
- •Dietary Restrictions
- •Restricted Oxalate Diet
- •Conservative Measures
- •Selective Medical Therapy
- •Absorptive Hypercalciuria
- •Thiazide
- •Orthophosphate
- •Renal Hypercalciuria
- •Primary Hyperparathyroidism
- •Hyperuricosuric Calcium Oxalate Nephrolithiasis
- •Enteric Hyperoxaluria
- •Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Distal Renal Tubular Acidosis
- •Chronic Diarrheal States
- •Thiazide-Induced Hypocitraturia
- •Idiopathic Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Hypomagnesiuric Calcium Nephrolithiasis
- •Gouty Diathesis
- •Cystinuria
- •Infection Lithiasis
- •Summary
- •References
- •12: Molecular Biology for Urologists
- •Introduction
- •Inherited Changes in Cancer Cells
- •VEGR and Cell Signaling
- •Targeting mTOR
- •Conclusion
- •References
- •13: Chemotherapeutic Agents for Urologic Oncology
- •Introduction
- •Bladder Cancer
- •Muscle Invasive Bladder Cancer
- •Metastatic Bladder Cancer
- •Conclusion
- •Prostate Cancer
- •Other Chemotherapeutic Drugs or Combinations for Treating HRPC
- •Conclusion
- •Renal Cell Carcinoma
- •Chemotherapy
- •Immunotherapy
- •Angiogenesis Inhibitor Drugs
- •Conclusion
- •Testicular Cancer
- •Stage I Seminoma
- •Stage I non-seminomatous Germ Cell Tumours (NSGCT)
- •Metastatic Germ Cell Tumours
- •Low-Volume Metastatic Disease (Stage II A/B)
- •Advanced Metastatic Disease
- •Salvage Chemotherapy for Relapsed or Refractory Disease
- •Conclusion
- •Penile Cancer
- •Side Effects of Chemotherapy
- •Conclusion
- •References
- •14: Tumor and Transplant Immunology
- •Antibodies
- •Cytotoxic and T-helper Cells
- •Immunosuppression
- •Induction Therapy
- •Maintenance Therapy
- •Rejection
- •Posttransplant Lymphoproliferative Disease
- •Summary
- •References
- •15: Pathophysiology of Renal Obstruction
- •Causes of Renal Obstruction
- •Effects on Prenatal Development
- •Prenatal Hydronephrosis
- •Spectrum of Renal Abnormalities
- •Renal Functional Changes
- •Renal Growth/Counterbalance
- •Vascular Changes
- •Inflammatory Mediators
- •Glomerular Development Changes
- •Mechanical Stretch of Renal Tubules
- •Unilateral Versus Bilateral
- •Limitations of Animal Models
- •Future Research
- •Issues in Patient Management
- •Diagnostic Imaging
- •Ultrasound
- •Intravenous Urography
- •Antegrade Urography and the Whitaker Test
- •Nuclear Renography
- •Computed Tomography
- •Magnetic Resonance Urography
- •Hypertension
- •Postobstructive Diuresis
- •References
- •Introduction
- •The Normal Lower Urinary Tract
- •Anatomy
- •Storage Function
- •Voiding Function
- •Neural Control
- •Symptoms
- •Flow Rate and Post-void Residual
- •Voiding Cystometry
- •Male
- •Female
- •Neurourology
- •Conclusions
- •References
- •17: Urologic Endocrinology
- •The Testis
- •Normal Androgen Metabolism
- •Epidemiological Aspects
- •Prostate
- •Brain
- •Muscle Mass and Adipose Tissue
- •Bones
- •Ematopoiesis
- •Metabolism
- •Cardiovascular System
- •Clinical Assessment
- •Biochemical Assessment
- •Treatment Modalities
- •Oral Preparations
- •Parenteral Preparations
- •Transdermal Preparations
- •Side Effects and Treatment Monitoring
- •Body Composition
- •Cognitive Decline
- •Bone Metabolism
- •The Kidneys
- •Endocrine Functions of the Kidney
- •Erythropoietin
- •Calcitriol
- •Renin
- •Paraneoplastic Syndromes
- •Hypercalcemia
- •Hypertension
- •Polycythemia
- •Other Endocrine Abnormalities
- •References
- •General Physiology
- •Prostate Innervation
- •Summary
- •References
- •Wound Healing
- •Inflammation
- •Proliferation
- •Remodeling
- •Principles of Plastic Surgery
- •Tissue Characteristics
- •Grafts
- •Flap
- •References
- •Lower Urinary Tract Symptoms
- •Storage Phase
- •Voiding Phase
- •Return to Storage Phase
- •Urodynamic Parameters
- •Urodynamic Techniques
- •Volume Voided Charts
- •Pad Testing
- •Typical Test Schedule
- •Uroflowmetry
- •Post Voiding Residual
- •Further Diagnostic Evaluation of Patients
- •Cystometry with or Without Video
- •Cystometry
- •Videocystometrography (Cystometry + Cystourethrography)
- •Cystometric Findings
- •Comment:
- •Measurements During the Storage Phase:
- •Measurements During the Voiding Phase:
- •Abnormal Function
- •Disorders of Sensation
- •Causes of Hypersensitive Bladder Sensation
- •Causes of Hyposensitive Bladder Sensation
- •Disorders of Detrusor Motor Function
- •Bladder Outflow Tract Dysfunction
- •Detrusor–Urethral Dyssynergia
- •Detrusor–Bladder Neck Dyssynergia
- •Detrusor–Sphincter Dyssynergia
- •Complex Urodynamic Investigation
- •Urethral Pressure Measurement
- •Technique
- •Neurophysiological Evaluation
- •Conclusion
- •References
- •Endoscopy
- •Cystourethroscopy
- •Ureteroscopy and Ureteropyeloscopy
- •Nephroscopy
- •Virtual Reality Simulators
- •Lasers
- •Clinical Application of Lasers
- •Condylomata Acuminata
- •Urolithiasis
- •Benign Prostatic Hyperplasia
- •Ureteral and Urethral Strictures
- •Conclusion
- •References
- •Introduction
- •The Prostatitis Syndromes
- •The Scope of the Problem
- •Category III CP/CPPS
- •The Goal of Treatment
- •Conservative Management
- •Drug Therapy
- •Antibiotics
- •Anti-inflammatories
- •Alpha blockers
- •Hormone Therapies
- •Phytotherapies
- •Analgesics, muscle relaxants and neuromodulators
- •Surgery
- •A Practical Management Plan
- •References
- •Orchitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment of Infectious Orchitis
- •Epididymitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation of Epididymitis
- •Treatment of Acute Epididymitis
- •Treatment of Chronic Epididymitis
- •Treatment of Spermatic Cord Torsion
- •Fournier’s Gangrene
- •Definition and Etiology
- •Risk Factors
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment
- •References
- •Fungal Infections
- •Candidiasis
- •Aspergillosis
- •Cryptococcosis
- •Blastomycosis
- •Coccidioidomycosis
- •Histoplasmosis
- •Radiographic Findings
- •Treatment
- •Tuberculosis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Schistosomiasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Filariasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Onchocerciasis
- •References
- •25: Sexually Transmitted Infections
- •Introduction
- •STIs Associated with Genital Ulcers
- •Herpes Simplex Virus
- •Diagnosis
- •Treatment
- •Chancroid
- •Diagnosis
- •Treatment
- •Syphilis
- •Diagnosis
- •Treatment
- •Lymphogranuloma Venereum
- •Diagnosis
- •Treatment
- •Chlamydia
- •Diagnosis
- •Treatment
- •Gonorrhea
- •Diagnosis
- •Treatment
- •Trichomoniasis
- •Diagnosis
- •Treatment
- •Human Papilloma Virus
- •Diagnosis
- •Treatment
- •Scabies
- •Diagnosis
- •Treatment
- •References
- •26: Hematuria: Evaluation and Management
- •Introduction
- •Classification of Hematuria
- •Macroscopic Hematuria
- •Microscopic Hematuria
- •Dipstick Hematuria
- •Pseudohematuria
- •Factitious Hematuria
- •Menstruation
- •Aetiology
- •Malignancy
- •Urinary Calculi
- •Infection and Inflammation
- •Benign Prostatic Hyperplasia
- •Trauma
- •Drugs
- •Nephrological Causes
- •Assessment
- •History
- •Examination
- •Investigations
- •Dipstick Urinalysis
- •Cytology
- •Molecular Tests
- •Blood Tests
- •Flexible Cystoscopy
- •Upper Urinary Tract Evaluation
- •Renal USS
- •KUB Abdominal X-Ray
- •Intravenous Urography (IVU)
- •Computed Tomography (CT)
- •Retrograde Urogram Studies
- •Magnetic Resonance Imaging (MRI)
- •Additional Tests and Renal Biopsy
- •Intractable Hematuria
- •Loin Pain Hematuria Syndrome
- •References
- •27: Benign Prostatic Hyperplasia (BPH)
- •Historical Background
- •Pathophysiology
- •Patient Assessment
- •Treatment of BPH
- •Watchful Waiting
- •Drug Therapy
- •Interventional Therapies
- •Conclusions
- •References
- •28: Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie´s Disease
- •Erectile Dysfunction
- •Introduction
- •Diagnosis
- •Basic Evaluation
- •Cardiovascular System and Sexual Activity
- •Optional Tests
- •Treatment
- •Medical Treatment
- •Oral Agents
- •Phosphodiesterase Type 5 (PDE 5) Inhibitors
- •Nonresponders to PDE5 Inhibitors
- •Apomorphine SL
- •Yohimbine
- •Intracavernosal and Intraurethral Therapy
- •Intracavernosal Injection (ICI) Therapy
- •Intraurethral Therapy
- •Vacuum Constriction Devices
- •Surgical Therapy
- •Conclusion
- •Peyronie´s Disease (PD)
- •Introduction
- •Oral Drug Therapy
- •Intralesional Drug Therapy
- •Iontophoresis
- •Radiation Therapy
- •Surgical Therapy
- •References
- •29: Premature Ejaculation
- •Introduction
- •Epidemiology
- •Defining Premature Ejaculation
- •Voluntary Control
- •Sexual Satisfaction
- •Distress
- •Psychosexual Counseling
- •Pharmacological Treatment
- •On-Demand Treatment with Tramadol
- •Topical Anesthetics
- •Phosphodiesterase Inhibitors
- •Surgery
- •Conclusion
- •References
- •30: The Role of Interventional Management for Urinary Tract Calculi
- •Contraindications to ESWL
- •Complications of ESWL
- •PCNL Access
- •Instrumentation for PCNL
- •Nephrostomy Drains Post PCNL
- •Contraindications to PCNL
- •Complications of PCNL
- •Semirigid Ureteroscopy
- •Flexible Ureteroscopy
- •Electrohydraulic Lithotripsy (EHL)
- •Ultrasound
- •Ballistic Lithotripsy
- •Laser Lithotripsy
- •Ureteric Stents
- •Staghorn Calculi
- •Lower Pole Stones
- •Horseshoe Kidneys and Stones
- •Calyceal Diverticula Stones
- •Stones and PUJ Obstruction
- •Treatment of Ureteric Colic
- •Medical Expulsive Therapy (MET)
- •Intervention for Ureteric Stones
- •Stones in Pregnancy
- •Morbid Obesity
- •References
- •Anatomy and Function
- •Pathophysiology
- •Management
- •Optical Urethrotomy/Dilatation
- •Urethral Stents
- •Preoperative Assessment
- •Urethroplasty
- •Anastomotic Urethroplasty
- •Substitution Urethroplasty
- •Grafts Versus Flaps
- •Oral Mucosal Grafts
- •Tissue Engineering
- •Graft Position
- •Conclusion
- •References
- •32: Urinary Incontinence
- •Epidemiology and Risk Factors
- •Pathophysiology
- •Urge Incontinence
- •Conservative Treatments
- •Pharmacotherapy
- •Invasive/ Surgical Therapies
- •Stress Urinary Incontinence
- •Male SUI Therapies
- •Female SUI Therapies
- •Mixed Urinary Incontinence
- •Conclusions
- •References
- •33: Neurogenic Bladder
- •Introduction
- •Examination and Diagnostic Tests
- •History and Physical Examination
- •Imaging
- •Urodynamics (UDS)
- •Evoked Potentials
- •Classifications
- •Somatic Pathways
- •Brain Lesions
- •Cerebrovascular Accident (CVA)
- •Parkinson’s Disease (PD)
- •Multiple Sclerosis
- •Huntington’s Disease
- •Dementias
- •Normal Pressure Hydrocephalus (NPH)
- •Tumors
- •Psychiatric Disorders
- •Spinal Lesions and Pathology
- •Intervertebral Disk Prolapse
- •Spinal Cord Injury (SCI)
- •Transverse Myelitis
- •Peripheral Neuropathies
- •Metabolic Neuropathies
- •Pelvic Surgery
- •Treatment
- •Summary
- •References
- •34: Pelvic Prolapse
- •Introduction
- •Epidemiology
- •Anatomy and Pathophysiology
- •Evaluation and Diagnosis
- •Outcome Measures
- •Imaging
- •Urodynamics
- •Indications for Management
- •Biosynthetics
- •Surgical Management
- •Anterior Compartment Repair
- •Uterine/Apical Prolapse
- •Enterocele Repair
- •Conclusion
- •References
- •35: Urinary Tract Fistula
- •Introduction
- •Urogynecologic Fistula
- •Vesicovaginal Fistula
- •Etiology and Risk Factors
- •Clinical Factors
- •Evaluation and Diagnosis
- •Pelvic Examination
- •Cystoscopy
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Urethrovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Ureterovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Vesicouterine Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Uro-Enteric Fistula
- •Vesicoenteric Fistula
- •Pyeloenteric Fistula
- •Urethrorectal Fistula
- •References
- •36: Urologic Trauma
- •Introduction
- •Kidney
- •Expectant Management
- •Endovascular Therapy
- •Operative Intervention
- •Operative Management: Follow-up
- •Reno-Vascular Injuries
- •Pediatric Renal Injuries
- •Adrenal
- •Ureter
- •Diagnosis
- •Treatment
- •Delayed Diagnosis
- •Bladder and Posterior Urethra
- •Bladder Injuries: Initial Management
- •Bladder Injuries: Formal Repair
- •Anterior Urethral Trauma
- •Fractured Penis
- •Penile Amputation
- •Scrotal and Testicular Trauma
- •Imaging
- •CT-IVP (CT with Delayed Images)
- •Technique
- •Cystogram
- •Technique
- •Retrograde Urethrogram (RUG)
- •Technique
- •Retrograde Pyelogram (RPG)
- •Technique
- •One-Shot IVP
- •Technique
- •References
- •37: Bladder Cancer
- •Who Should Be Investigated?
- •Epidemiology
- •Risk Factors
- •Role of Screening
- •Signs and Symptoms
- •Imaging
- •Cystoscopy
- •Urine Tests
- •PDD-Assisted TUR
- •Pathology
- •NMIBC and Risk Groups
- •Intravesical Chemotherapy
- •Intravesical Immunotherapy
- •Immediate Cystectomy and CIS
- •Radical Cystectomy with Pelvic Lymph Node Dissection
- •sexual function-preserving techniques
- •Bladder-Preservation Treatments
- •Neoadjuvant Chemotherapy
- •Adjuvant Chemotherapy
- •Preoperative Radiotherapy
- •Follow-up After TUR in NMIBC
- •References
- •38: Prostate Cancer
- •Introduction
- •Epidemiology
- •Race
- •Geographic Variation
- •Risk Factors and Prevention
- •Family History
- •Diet and Lifestyle
- •Prevention
- •Screening and Diagnosis
- •Current Screening Recommendations
- •Biopsy
- •Pathology
- •Prognosis
- •Treatment of Prostate Cancer
- •Treatment for Localized Prostate Cancer (T1, T2)
- •Radical Prostatectomy
- •EBRT
- •IMRT
- •Brachytherapy
- •Treatment for Locally Advanced Prostate Cancer (T3, T4)
- •EBRT with ADT
- •Radical Prostatectomy
- •Androgen-Deprivation Therapy
- •Summary
- •References
- •39: The Management of Testis Cancer
- •Presentation and Diagnosis
- •Serum Tumor Markers
- •Primary Surgery
- •Testis Preserving Surgery
- •Risk Stratification
- •Surveillance Versus Primary RPLND
- •Primary RPLND
- •Adjuvant Treatment for High Risk
- •Clinical Stage 1 Seminoma
- •Risk-Stratified Adjuvant Treatment
- •Adjuvant Radiotherapy
- •Adjuvant Low Dose Chemotherapy
- •Primary Combination Chemotherapy
- •Late Toxicity
- •Salvage Strategies
- •Conclusion
- •References
- •Index
79
imaging of thE UPPEr tracts
Figure 5.20. coronal reformat image from a non-contrast ct demonstrates a left proximal mid ureteric calculus (arrow) causing renal obstruction.
multiplanar reformats (Fig. 5.23) as well as detailed 3-D images. This facility is particularly useful for surgical planning in those patients with complex stone disease being considered for percutaneous nephrolithotomy or ureteroscopy.
Renal Cystic Disease
Benign Renal Cysts
Benign or “simple” renal cysts are common and may be seen in at least 50% of the population over the age of 60. The majority are situated in the renal cortex and are usually asymptomatic although larger cysts can enlarge leading to pressure symptoms. Occasionally, benign cysts become infected resulting in sepsis or undergo hemorrhage giving rise to flank pain. Symptomatic cysts can often be managed by radiologically guided percutaneous drainage.
On ultrasound, simple cysts are unilocular anechoic structures with associated posterior acoustic enhancement (Fig. 5.24). On CT they can be recognized as rounded non-enhancing homogenous fluid density structures. Renal cysts are not usually identifiable IVU, however larger cysts can result in lobulation of the renal outline or distortion the renal collecting system.
|
|
Hereditary Renal Cystic Disease |
|
|
Adult polycystic kidney disease (APCKD) is an |
|
|
autosomal dominant condition, which usually |
|
|
presents in the third or fourth decade of life. |
|
|
Clinical features can include flank pain, hematu- |
|
|
ria, hypertension, or a palpable loin mass. There |
Figure 5.21. mid-ureteric calculus on a non-contrast ct with |
|
is gradual decline in renal function and need for |
|
long-term dialysis. Imaging demonstrates |
|
associated“soft tissue rim sign” indicating ureteric edema. |
|
parenchymal replacement by numerous bilat- |
|
||
|
|
eral cysts throughout the renal cortex and |
CT can identify certain nonobstructive renal |
medulla. The cysts tend to vary in size and con- |
|
conditions and extrarenal pathologies, which |
tent, often containing proteinaceous fluid or |
|
can sometimes present with flank pain indistin- |
blood resulting in high attenuation on CT. |
|
guishable from ureteric colic (Table 5.4). It may |
Von Hippel Lindau disease is also an auto- |
|
be necessary in these cases to administer intra- |
somal dominant condition, which is character- |
|
venous contrast to fully evaluate the underlying |
ized by the presence of retinal angiomas, central |
|
abnormality.11 |
nervous system hemangioblastomas, and |
|
For patients with complex stone disease CT |
abdominal lesions. Renal tumors and cysts are |
|
urography provides useful information regard- |
important features of this condition. Unlike |
|
ing stone morphology and renal anatomy. Post- |
APCKD, the cysts are associated with increased |
|
processing techniques allow construction of |
risk of malignancy. |
80
Practical Urology: EssEntial PrinciPlEs and PracticE
a |
b |
Figure 5.22. Paired images: (a) the axial ct image shoes a distal right ureteric calculus (arrow), which is clearly visible on the (b) accompanying scout image (arrow) indicating follow-up imaging by plain radiographs could be carried out if required.
Table 5.4. nonobstructive renal and nonrenal causes of flank pain
nonobstructive renal causes of flank pain
•Acutepyelonephritis
•Renaltumor
•Renalhemorrhage
•Renalinfarction
•Renalveinthrombosis
nonrenal causes of flank pain
•Appendicitis
•Diverticulitis
•Pelvicinflammatorydisease
•Cholecystitis
•Aorticaneurysm
Parapelvic renal cysts arise adjacent to the renal pelvis resulting in extrinsic compression of the renal collecting system.They tend to contain lymphatic fluid and are usually asymptomatic. On ultrasound they can be seen as rounded anechoic structures situated in the renal medulla.
Occasionally, parapelvic cysts can give rise to diagnostic confusion on ultrasound and on unenhanced CT as their appearance can be difficult to distinguish from hydronephrosis. On IVP, they may result in distortion and stretching of the pelvicalyceal system. Definitive diagnosis
Figure 5.23. coronal ct urography image demonstrating the presence of renal calculi within the left lower pole calyx.there is generalized left renal cortical atrophy.
can be made by CT urography, which opacifies the collecting system and allows the cysts to be identified separately (Fig. 5.25).
Complex Renal Cysts
Complex renal cysts demonstrate atypical features that may warrant follow-up or consideration of surgical removal. Atypical features include, increased wall thickness, nodularity, septations, calcification, or internal contents not typical for simple fluid. Complex renal cysts are usually evaluated by CT. MRI can also help further characterize complex cysts and may be useful as a supplementary test.
81
imaging of thE UPPEr tracts
|
|
1 cysts are noncomplex renal cysts that can be |
|
|
|
safely regarded as benign and do not require fol- |
|
|
|
low-up. Bosniak category 2 lesions are cysts with |
|
|
|
subtle atypical features such as fine septations and |
|
|
|
minor calcification, these are also benign. |
|
|
|
Hemorrhagic cysts also fall into this category. |
|
|
|
Bosniak 3 cysts are lesions which demonstrate |
|
|
|
prominent atypical features such as wall and |
|
|
|
septal thickening, nodularity, coarse calcifica- |
|
|
|
tions and may also demonstrate enhancement. |
|
|
|
These are potentially malignant lesions that may |
|
|
|
warrant surgical removal. Bosniak 4 lesions are |
|
|
|
frankly malignant cystic masses.12 |
|
|
|
Class 2F lesions are cysts that cannot easily be |
|
|
|
classified as Bosniak 2 or 3 lesions, close follow- |
|
|
|
up imaging of these lesions is indicated. |
|
|
|
Renal cysts may also occur in association with |
|
Figure 5.24. |
Ultrasound image demonstrating a benign renal |
dialysis. These occur in up to 50% of patients on |
|
long-term hemodialysis. There is an increased |
|||
cyst. |
|
||
|
risk of malignant change in these cysts. |
||
|
|
Figure 5.25. ct urography: Para pelvic cysts are seen as homogenous low attenuation structures adjacent to the opacified pelvicalyceal system.
The Bosniak classification, which is based on CT appearances is used to categorize renal cysts in increasing order of complexity and radiological concern (Table 5.5 and Fig.5.26).Bosniak category
Upper Tract Infective and
Inflammatory Disease
Most patients with urinary tract infections do not require imaging investigations. However, imaging may be appropriate in those patients with severe recurrent infections to identify any underlying renal tract abnormality. Ultrasound is a useful first-line test to assess renal morphology and is frequently used to investigate patients with recurrent UTIs. IVU or CT urography may also be helpful in identifying any underlying upper tract abnormality.
Chronic pyelonephritis results in renal scarring, atrophy, and distortion of the renal calyces and is readily appreciated on ultrasound or CT.
Urosepsis: In this situation it is important to distinguish between pyelonephritis, which is treated medically from other causes of urosepsis such as,pyonephrosis,renal abscess,and emphysematous pyelonephritis, which may require surgical or radiological intervention.
Acute Pyelonephritis can be diffuse or focal. Characteristic changes on ultrasound include swelling of the kidney, reduced echogenicity as a result of parenchymal edema, and diminished vascularity. However, ultrasound is a relatively insensitive test for the assessment of acute pyelonephritis and may underestimate the severity of the disease.
82
Practical Urology: EssEntial PrinciPlEs and PracticE
Table 5.5. Bosniak classification of renal cysts |
|
|
Category |
CT features |
Significance |
class 1 |
Water density, homogenous, noncalcified, |
Benign |
|
smooth margin, no enhancing component |
|
class 2 |
thin septae (<1 mm) , thin calcification |
Benign |
|
(<1 mm), hemorrhagic cysts |
|
class 2f |
|
likely benign, follow-up |
|
|
imaging indicated |
class 3 |
thick septa, thick wall, thick calcification, |
approximately 50% |
|
multilocular +/− enhancement |
malignant |
class 4 |
Enhancing solid mass component, i.e., cystic |
definitely malignant |
|
carcinomas |
|
a b
c |
d |
Figure 5.26. (a–d) series of ct images showing various renal cysts. image (a) shows a non-complex homogenous (Bosniak 1) renalcyst.image(b)demonstratesacystcontainingfineseptations
(Bosniak 2 lesion).cyst containing coarse calcification and soft tissue component (c) in keeping with a Bosniak 3 cyst. image (d) demonstrates a malignant cystic mass (Bosniak 4 lesion).
83
imaging of thE UPPEr tracts
a |
b |
Figure 5.27. (a) axial and (b) coronal ct images demonstrate diffuse abnormal enhancement and swelling of the left kidney with soft tissue stranding in the perinephric fat.appearances are
CT features of acute pyelonephtitis include patchy or wedge shaped low attenuation poorly enhancing areas within the renal parenchyma and swelling of the affected kidney often with inflammatory changes in the perinephric fat13 (Fig. 5.27).
Renal abscess can arise secondary to severe pyelonephritis or may be associated with underlying stone or cystic disease. On ultrasound renal abscess can be recognized as a thick walled cystic structure, which may contain echogenic fluid indicating internal debris.
CT typically demonstrates a thick walled enhancing fluid containing structure (Fig. 5.28).
Figure 5.28. thick walled fluid collection demonstrated in the upper pole of right kidney (white arrow) in patient with swinging pyrexia and leucocytosis, appearances indicate renal abscess.
in keeping with acute pyelonephritis.note also the presence of a small left renal calculus (arrow).
The presence of gas within a renal fluid collection is virtually diagnostic for abscess.
Renal abscesses can be treated with antimicrobial therapy but percutaneous drainage may be necessary if conservative measures fail.
Emphysematous Pyelonephritis is a rare lifethreatening condition in which there is severe renal infection resulting in gas formation within the renal parenchyma.The vast majority of cases (90%) are seen in diabetic patients. CT readily demonstrates abnormal renal enhancement and presence of gas in the renal parenchyma which is diagnostic for emphysematous pyelonephritis (Fig. 5.29). Nephrectomy is indicated if conservative measures fail.
Pyonephrosis: Pus in an obstructed renal collecting system can lead to life-threatening sepsis and is a urological emergency. Urgent decompression of the kidney either by nephrostomy drain or ureteric stent is indicated.
Pyonephrosis commonly occurs in kidneys obstructed by ureteric calculi although can occur secondary to any cause of renal obstruction. Ultrasound typically demonstrates hydronephrosis, which in the context of flank pain and pyrexia strongly suggests the diagnosis of pyonephrosis. Echogenic fluid within the collecting system or sedimented debris representing purulent material within the renal pelvis is also sometimes a feature (Fig. 5.30).
Xanthogranulomatous pyelonephritis (XPN) is an inflammatory renal condition associated with chronic urinary tract infection (usually caused
84
Practical Urology: EssEntial PrinciPlEs and PracticE
a |
b |
Figure 5.29. (a, b) ct scan images in a patient with poorly controlled diabetes and pyrexia of unknown origin. Pockets of gas are present in the renal parenchyma (white arrow) and perinephric space (yellow arrows) which confirm the diagnosis of
emphysematous pyelonephritis. the patient was successfully treated with antibiotics and ureteric stent insertion. images courtesy of mr. nigel Boucher (consultant Urological surgeon, chesterfield royal lnfirmary).
Figure 5.30. Ultrasound in a patient with loin pain and fever shows a severely hydronephrotic kidney with an obstructing calculus at the pelvi-ureteric junction (yellow arrow). Echogenic fluid is identified in the collecting system in keeping with pyonephrosis.
by E. Coli or Proteus species). Histologically, the kidney is infiltrated by lipid laden macrophages, which destroy the normal renal parenchyma. Clinical features include flank pain and pyrexia. The condition is usually unilateral, more common in women and can be focal or diffuse.
CT usually demonstrates renal enlargement with replacement of normal renal parenchyma by areas of low attenuation of xanthomatous tissue (Fig. 5.31). Associated stone formation, usually of the staghorn type is seen in up to 80% of cases. Extrarenal extension of XPN into the perinephric fat, Gerotas fascia, and adjacent psoas muscle is a common feature.
Figure 5.31. Xanthogranulomatous pyelonephritis ct scan demonstrates an enlarged inflamed kidney. multiple renal calculi and abnormal parenchymal enhancement is shown. note extension of infection into the perinephric fat (arrow).
Imaging of Upper Urinary Tract
Obstruction
There are many causes for obstruction of the upper urinary tract, which can occur at any level between the pelvi ureteric junction and bladder. Causes can be divided into intrinsic pathology arising within the renal tract or extrinsic (Table 5.6). Hydronephrosis, dilatation of the pelvicalyceal system is the main imaging feature of renal obstruction. Depending on the
85
imaging of thE UPPEr tracts
Table 5.6. intrinsic and extrinsic causes of upper urinary tract obstruction
Intrinsic |
Extrinsic |
calculus |
lymphadenopathy |
transitional cell carcinoma |
retroperitoneal fibrosis |
PUJ obstruction |
Pelvic cancer,e.g.,prostate, |
congenital megaureter |
rectosigmioid,cervix |
schistosomiasis,tB |
Pregnancy |
|
abdominal abscess |
Prostatic carcinoma |
crossing vessels |
fungus ball |
Endometriosis |
underlying etiology renal obstruction may lead to a gradual or acute deterioration in renal biochemistry.
Ultrasound has a sensitivity of almost 100% for the detection of hydronephrosis, which is easily appreciated as dilatation of the renal pelvis and calyces (Fig. 5.32) and is commonly performed as a first-line test in suspected renal obstruction.14 Hydronephrosis, however, does not always indicate obstruction and is sometimes seen in well-hydrated patients and in those with bladder distension. Para pelvic cysts (Fig. 5.33), extra renal pelvis, and prominent renal vasculature can mimic hydronephrosis potentially leading to a false positive diagnosis
Figure 5.32. hydronephrotic kidney demonstrated by ultrasound. the renal cortical thickness is preserved in keeping with acute obstruction.
Figure 5.33. Parapelvic cysts: commonly misinterpreted as hydronephrosis. the presence of noncommunicating anechoic areas with separating septations representing the walls of the cysts helps differentiate this appearance from hydronephrosis.
of renal obstruction. Cortical atrophy is usually seen in chronic obstructive uropathy.
Obstructing pelvic masses may be visible on ultrasound; however, the retroperitoneal structures are frequently obscured by overlying bowel gas and alternative imaging tests are often necessary to demonstrate the underlying obstructing pathology.
Delayed contrast excretion, a dense nephrogram, and hydronephrosis are the principal IVU features of acute obstruction (Fig. 5.34). Associated hydroureter may also be evident depending on the level of obstruction. Obstructing ureteric calculi and ureteric can often be identified. However, extrinsic causes of renal obstruction cannot in most cases be diagnosed by IVU. Absence of renal excretion is seen in cases of severe acute obstruction or chronic obstructive uropathy.
Unenhanced CT has a high sensitivity for the detection of renal calculi and is the most accurate imaging modality for investigation of suspected obstructing ureteric calculi10. CT urography can readily demonstrate obstructing ureteric tumors as well as extrinsic abdominal or pelvic masses. Hydronephrosis with associated reduced parenchymal enhancement and cortical atrophy are features of chronic obstructive uropathy (Fig. 5.35).
MRI is useful for the assessment of patients with renal obstruction in those patients with renal impairment or iodine contrast allergy. MRI is particularly valuable for the diagnosis
86
Practical Urology: EssEntial PrinciPlEs and PracticE
Figure 5.34. iVU image demonstrating a right PUJ obstruction.
and evaluation of pelvic masses and is superior to CT for the local staging of bladder and prostate tumors. Heavily T2-weighted sequences are utilized to demonstrate the degree and level of ureteric obstruction15 (Fig. 5.36). The main disadvantage of MRI is its inability to adequately demonstrate obstructing ureteric calculi.
Management of Acute Renal
Obstruction
Urgent decompression of the upper renal tracts is indicated in patients with renal obstruction resulting in acute renal failure or urosepsis. This can be achieved by percutaneous nephrostomy tube (Fig. 5.37) or ureteric stent insertion.
Percutaneous renal drainage via a nephrostomy tube involves the insertion of a catheter into the kidney under imaging guidance and results in rapid decompression of the collecting system.
Typically the procedure is performed under local anasthesia. Complications are uncommon but include renal hemorrhage, sepsis, and inadvertent damage to surrounding organs. Nephrostomy drains can be left in situ until definitive treatment of the underlying cause of obstruction is dealt with.
Ureteric stents provide internal drainage of the upper tracts and are usually inserted retrogradely via a cystoscope. The main advantages over nephrostomy tubes are patient convenience as external drainage bags are not needed and avoidance of trauma to the renal parenchyma with less risk of hemorrhagic complications. The procedure is usually performed under general anasthesia. Retrograde stent insertion may be difficult or impossible in patients with extensive pelvic malignancy, in these patients antegrade ureteric stent insertion via a nephrostomy track may be feasible.
a |
b |
Figure 5.35. (a, b) contrast-enhanced ct demonstrates bilateral hydronephrosis. a para-aortic soft tissue mass is shown (arrow) indicating retroperitoneal fibrosis.